Aerie Pharmaceuticals Inc (AERI) Return on Investment ROI from the third quarter of 2022 to third quarter of 2021 and for the year 2022, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aerie Pharmaceuticals Inc   (NASDAQ: AERI)


Aerie Pharmaceuticals Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Aerie Pharmaceuticals Inc's ROI in the third quarter of 2022?
Aerie Pharmaceuticals Inc recorded a cumulative net loss of $-37 million during 12 months ending in the third quarter of 2022, resulting in a negative return on investment (ROI) of -13.36%.

Within the Healthcare sector 347 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2022 from 0 to 3793.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Investment Change TTM 4.44 % -0.59 % -6.86 % -12.66 % -20 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 242 266 280 306 234
Return On Investment (TTM) -13.36 % -18.2 % -25.75 % -28.31 % -63.54 %
AERI's Overall Ranking # 3793 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 0.79 % 1.71 % 1.03 % 0.84 % -4.06 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -37 -49 -69 -75 -166

AERI Company Profile >> Back to AERI Roi Comparisons >> See Annual AERI Return On Investment



Return On Investment AERI's Ranking
Within: No.
Industry # 39
Sector # 348
Overall # 3793

Return On Investment Statistics
High Average Low
-13.36 %
-55.9 %
-103.95 %
(Sep 30 2022)   (Jun 30 2019)







Financial Statements
Aerie Pharmaceuticals Inc's III. Quarter Investments $ 242 Millions AERI's Balance sheet
Aerie Pharmaceuticals Inc's III. Quarter Income $ -27 Millions Quarterly AERI's Income Statement
AERI's Income by Division See AERI's Income by Division


AERI Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 306 298 369 234 265
Y / Y Investment Growth 2.97 % -19.35 % 57.5 % -11.63 % 15.82 %
Net Income in Millions -75 -183 -200 -233 -145
Y / Y Net Income Growth - - - - -
Annual Return On Investment -24.42 % -61.53 % -54.09 % -99.28 % -54.74 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AERI's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AERI's Competitors
Subscribers only: Roi for Aerie Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for AERI's Customers

Other Ratios
AERI's Roa AERI's Inventory Turnover Ratio AERI's Growth Rates AERI's Dividend Statistics
AERI's Profitability Ratios AERI's Asset Turnover Ratio AERI's Dividend Growth
AERI's Roe AERI's Valuation Ratios AERI's Financial Strength Ratios AERI's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI

Date modified: 2026-08-29T17:18:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.